GLP-1s and Gallstones: What the Research Really Shows

GLP-1 medications can increase the risk of gallstones and related gallbladder problems, but for most people the added risk is small. Gallstones are hardened deposits that form in the gallbladder, the small organ that stores bile to help digest fat. The strongest evidence comes from a systematic review and meta-analysis of 76 randomized trials with over 100,000 participants, published in *JAMA Internal Medicine* in 2022. It found that people randomized to a GLP-1 receptor agonist had a 37% higher relative risk of gallbladder or biliary disease (relative risk 1.37; 95% CI, 1.23–1.52). "Relative risk" describes the increase compared to people not on the drug — it doesn't mean 37% of users get gallstones. The same analysis put the absolute increase at about 27 extra cases per 10,000 people treated per year, which is modest. So the effect is real but not a reason to panic for most users.

There are two main mechanisms, and they stack. First, GLP-1 drugs appear to slow the movement of the gallbladder and bile ducts. When the gallbladder empties less often, bile sits and can thicken into sludge and then stones. This is related to the same slowed-motility effect that causes [constipation on GLP-1s](/blog/constipation-on-wegovy-fiber-and-hydration-protocol) and delayed stomach emptying. Second, rapid weight loss itself — from any cause, not just these drugs — raises gallstone risk, because quickly mobilizing fat increases cholesterol in the bile and can supersaturate it. Since GLP-1s can produce fast, substantial weight loss, this compounds the direct drug effect. The 2022 meta-analysis specifically found risk was higher at higher doses, with longer duration, and when the drugs were used for weight loss rather than diabetes — all consistent with the weight-loss-speed explanation. Understanding [how GLP-1s work](/blog/how-glp-1-medications-work-incretin-mechanism-explained) makes these effects easier to anticipate.

The classic red flag is a gallbladder attack: sudden, intense, steady pain in the upper-right part of your abdomen or just below the breastbone, often starting after a fatty meal and sometimes radiating to the right shoulder or back. Attacks can last from 15 minutes to several hours. Other symptoms include nausea and vomiting, and — more seriously — yellowing of the skin or eyes (jaundice), fever, chills, or dark urine, which can signal a blocked bile duct or infected gallbladder and need urgent care. It's worth distinguishing this from routine GLP-1 side effects: everyday [GLP-1 nausea](/blog/glp1-nausea-why-it-happens-and-how-to-stop-it) is usually mild, dose-related, and improves with time, whereas a gallbladder attack is a distinct, severe, localized pain. If you're ever unsure, or the pain is severe or comes with fever or jaundice, seek medical care promptly.

You can't eliminate the risk, but several habits may help. Aim for steady, not extreme, weight loss — following the dose-escalation schedule your provider set rather than rushing gives your gallbladder time to adjust. Don't skip meals or crash-diet; eating regular meals that contain some fat prompts the gallbladder to contract and empty, which discourages sludge. Stay well hydrated and get enough fiber, which supports healthy digestion and bile flow. Some evidence suggests dietary fat that triggers normal gallbladder contraction is actually protective compared with very-low-fat eating. If you have a history of gallstones, tell your prescriber before starting. None of these steps are guaranteed, but they align with what the research suggests drives risk — speed of weight loss and bile stasis. Being consistent also helps you avoid stalls; see our guide on [breaking a weight-loss plateau](/blog/glp1-weight-loss-plateau-how-to-break-a-stall).

For most people, no. The absolute risk increase — around 27 additional cases per 10,000 people per year — is small compared with the substantial metabolic and cardiovascular benefits these drugs provide for people who need them. The decision should be individualized: someone with a prior history of gallstones, or who is losing weight very rapidly, may warrant closer monitoring, while many others will never have a problem. The goal isn't to avoid the medication out of fear but to be informed: know the warning symptoms, pursue steady weight loss, and keep your provider in the loop. If a gallbladder issue does develop, it's usually treatable, sometimes with removal of the gallbladder, after which people typically continue living normally. As always, weigh this alongside your other health goals with your doctor.